Human Longevity

Human Longevity Inc. (HLI) is a genomics and cell therapy-based diagnostic and therapeutic company. Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building a comprehensive database on human genotypes and phenotypes to tackle the diseases associated with aging-related human biological decline. HLI is also leading the development of cell-based therapeutics to address age-related decline in endogenous stem cell function. HLI is concentrating on cancer, diabetes and obesity, heart and liver diseases, and dementia.
Company Growth (employees)
San Diego, US
Size (employees)
283 (est)+4%
Human Longevity was founded in 2013 and is headquartered in San Diego, US

Key People at Human Longevity

William Roper

William Roper

Robert Hariri

Robert Hariri

Co-Founder, President
William Biggs

William Biggs

Head, Genomic Sequencing
Kenneth Bloom

Kenneth Bloom

Head of Oncology

Human Longevity Office Locations

Human Longevity has offices in San Diego, Mountain View and Singapore
San Diego, US (HQ)
4570 Executive Dr
Mountain View, US
100 View St

Human Longevity Data and Metrics

Summary Metrics

Founding Date


Total Funding

$300 m

Latest funding size

$220 m

Time since last funding

over 1 year


Human Longevity's latest funding round in April 2016 was reported to be $220 m. In total, Human Longevity has raised $300 m. Human Longevity's latest valuation is reported to be $1.2 b.

Human Longevity Financial Metrics


Market valuation

1.2 b

Human Longevity Job Categories

Traffic Overview of Human Longevity

Human Longevity Online and Social Media Presence

Human Longevity News and Updates

Forever Young: 10 Anti-Aging Startups To Watch

By 2050, the US population aged 65 and older is projected to reach 83.7M, almost double its population in 2012. To combat the aging process and help people lead longer and healthier lives, pharmaceutical corporates and tech giants alike have … Continued

A British tech unicorn is trying to cure Alzheimer's and ALS with artificial intelligence

There is no cure for Alzheimer's, even though it's one of the most common diseases in older people.It takes a lot of time and money to produce even the most everyday medicines, let alone a cure for something like Alzheimer's.According to the Association of the British Pharm…

How Life (and Death) Spring From Disorder

As simple systems show signs of life, scientists are arguing about whether this apparent complexity is all a consequence of thermodynamics. The post How Life (and Death) Spring From Disorder appeared first on WIRED.

$1B+ Market Map: The World’s 186 Unicorn Companies In One Infographic

There are 186 private companies around the world as of 1/18/2017 that are valued at $1B+, all tracked on our real-time unicorn tracker. Collectively, these companies are worth approximately $656B. Combined, they have raised approximately $126B. Forty-two of these private companies became … Continued

Illumina wants to sequence your whole genome for $100

 The first sequencing of the whole human genome in 2003 cost roughly $2.7 billion but DNA sequencing giant Illumina has now unveiled a new machine that the company says is “expected one day” to order up your whole genome for less than $100. Illumina’s CEO Frank deSouza showed off the machine, called…

How do liberals halt the march of the right? Stand our ground and toughen up | Matthew d’Ancona

We can fight bigotry and prejudice if we’re prepared to challenge, probe and correct – relentlesslyTo all you despondent liberals, Labour centrists, Tory modernisers, remainers, social justice warriors, social justice worriers, and everyone out there fretful about Brexit, depressed by Donald Trump, …
Show more

Human Longevity Company Life and Culture

You may also be interested in